Both the Sutton and Chelsea sites offer unrivalled
facilities, cutting-edge technology, a comfortable and modern environment, state-of-the-art surgical theatres and countless private rooms.
Pioneering treatment and technology Our private patients have access to pioneering treatment and leading edge technology. Examples include CyberKnife, an advanced radiotherapy machine which uses image guidance to deliver radiotherapy with pin point accuracy to affected areas; Neo-adjuvant chemotherapy is given to patients before surgery who have been identified as likely to benefit from this through genetic testing, and the minimally invasive da Vinci S robotic surgery system significantly reduces the amount of time it takes patients to recover from operations. Another such example of this state-of-the-art
technology which will be available to patients of The Royal Marsden is the MR Linac system. The Royal Marsden and The Institute of Cancer Research will become the first institutions in the UK to own one of world’s most advanced radiotherapy machines, thanks to a £9.6 million grant. The MR Linac system combines an MRI scanner and a linear accelerator. Once fully developed for the clinic, it will enable more accurate targeting of tumours immediately before and during treatment, particularly of those that move such as prostate, lung and breast cancers. In addition to the above, the Sutton site houses
the internationally-acclaimed centre of excellence for paediatric care, which includes the multi– million pound Oak Centre for Children and Young People. And in Chelsea the Rapid Diagnostic and Assessment Centre (RDAC) is located, which is a one-stop-shop for quick and accurate diagnosis and testing, significantly reducing waiting times for patients. We have also recently invested in the brand new
Reuben Imaging Centre, which is equipped with the latest technologically advanced MRI scanners and CT scanners, thanks to £6.9 million raised by The Royal Marsden Cancer Charity. MRI scans enable us to look at a tumour in fine detail. They are particularly important for soft-tissue cancers, such as brain, spinal cord, bowel, gynaecological and prostate cancers, as the magnetic resonance uses the properties of the soft tissue to create the detail in the image. And CT scanners use X-rays to produce cross-sectional images of the body. When the images are reassembled by computer, the result is a detailed 3D view of the body’s interior. CT scans can be used to help make a cancer diagnosis or assess the effects of cancer treatment.
Research and drug development We work very closely with The Institute of Cancer Research (ICR) and together have the status of biomedical Research Centre (BRC) – the only one in the UK dedicated to cancer. With Professor David Cunningham, Director of Clinical Research, as Theme Lead, the BRC Clinical Studies Theme harnesses the latest knowledge in molecular pathology, cancer imaging and drug development
32 Global Opportunity Healthcare 2015 | Issue 01
‘Researchers ensure that information flows between the laboratory and the clinic to rapidly translate findings into benefits for patients.’
to offer our patients a personalised treatment plan within innovative clinical trials. Researchers ensure that information flows
between the laboratory and the clinic to rapidly translate findings into benefits for patients. They also work closely with many of the other themes as part of an integrated approach, usually in collaboration with other BRCs and cancer centres nationally.
Overseas patients services At the hospital we attract many patients from the Middle East and have seen a rise in Arab patients opting to come to us for private care, as well as patients from Russia, Greece and Malta. We employ multi-national hospital staff, with many
able to speak and understand Arabic and other languages. The hospital also provides a dedicated Arabic Advocate Service to support those choosing to come to The Royal Marsden for treatment or
The hospital is equipped with advanced MRI and CT scanners
global-opportunity.co.uk
|
The Royal Marsden
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68 |
Page 69 |
Page 70 |
Page 71 |
Page 72 |
Page 73 |
Page 74 |
Page 75 |
Page 76 |
Page 77 |
Page 78 |
Page 79 |
Page 80 |
Page 81 |
Page 82 |
Page 83 |
Page 84 |
Page 85 |
Page 86 |
Page 87 |
Page 88 |
Page 89 |
Page 90 |
Page 91 |
Page 92 |
Page 93 |
Page 94 |
Page 95 |
Page 96 |
Page 97 |
Page 98 |
Page 99 |
Page 100 |
Page 101 |
Page 102 |
Page 103 |
Page 104 |
Page 105 |
Page 106 |
Page 107 |
Page 108 |
Page 109 |
Page 110 |
Page 111 |
Page 112 |
Page 113 |
Page 114 |
Page 115 |
Page 116 |
Page 117 |
Page 118 |
Page 119 |
Page 120 |
Page 121 |
Page 122 |
Page 123 |
Page 124 |
Page 125 |
Page 126 |
Page 127 |
Page 128